يعرض 1 - 4 نتائج من 4 نتيجة بحث عن '"HER2+"', وقت الاستعلام: 0.64s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Inhibition of CDK8/19 Mediator kinase potentiates HER2-targeting drugs and bypasses resistance to these agents in vitro and in vivo.

    المؤلفون: Xiaokai Ding1, Sharko, Amanda C.1, McDermott, Martina S. J.1, Schools, Gary P.1, Chumanevich, Alexander1, Hao Ji1, Jing Li1, Li Zhang1, Mack, Zachary T.1, Sikirzhytski, Vitali1, Shtutman, Michael1, Ivers, Laura2, O'Donovan, Norma2, Crown, John2, Gyõrffy, Balázs3,4, Chen, Mengqian1,5, Roninson, Igor B.1, Broude, Eugenia V.1 broude@cop.sc.edu

    المصدر: Proceedings of the National Academy of Sciences of the United States of America. 8/9/2022, Vol. 119 Issue 32, p1-11. 52p.

    مصطلحات موضوعية: *HER2 positive breast cancer, *DRUG resistance, *ELECTROCONVULSIVE therapy, *PROTEIN-tyrosine kinases, *TRASTUZUMAB, *BRCA genes, *HEMOPHILIACS

    النص الكامل

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Seventeen-gene signature from enriched Her2/Neu mammary tumor-initiating cells predicts clinical outcome for human HER2+:ERα- breast cancer.

    المؤلفون: Liu, Jeff C.1, Voisin, Veronique2, Bader, Gary D.2,3, Tao Deng1, Pusztai, Lajos4, Symmans, William Fraser5, Esteva, Francisco J.4, Egan, Sean E.3,6, Zacksenhaus, Eldad1,7,8 eldad.zacksenhaus@utoronto.ca

    المصدر: Proceedings of the National Academy of Sciences of the United States of America. 4/10/2012, Vol. 109 Issue 15, p5332-5837. 6p.

    مصطلحات موضوعية: *HER2 protein, *BREAST cancer, *TRASTUZUMAB, *IMMUNE response, *STROMAL cells

    النص الكامل

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    HER2[supYVMA] drives rapid development ofadenosquamous lung tumors in mice that are sensitive to B1BW2992 and rapamycin combination therapy.

    المؤلفون: Perera, Samanthi A.1,2, Danan Li1,2, Shimamura, Takeshi1, Raso, Maria G.3, Hongbin Ji4, Liang Chen1,2, Borgman, Christa L.1, Zaghiul, Sara1, Brandstetter, Kathleyn A.1, Kubo, Shigeto5, Takahashi, Masaya5, Chirieac, Lucian R.6, Padera, Robert F.6, Bronson, Roderick T.7, Shapiro, Geoffrey I.1, GreuIich, Heidi1,8, Meyerson, Matthew1,8, GuertIer, Ulrich9, Chesa, Pilar Garin9, SoIca, Flavio9

    المصدر: Proceedings of the National Academy of Sciences of the United States of America. 1/13/2009, Vol. 106 Issue 2, p474-479. 6p. 3 Color Photographs, 1 Graph.

    مصطلحات موضوعية: *HER2 gene, *LUNG cancer treatment, *RAPAMYCIN, *TRASTUZUMAB, *PROTEIN-tyrosine kinases, *IMMUNOHISTOCHEMISTRY, *THERAPEUTICS

    النص الكامل

    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    Microfluidic processor allows rapid HER2 immunohistochemistry of breast carcinomas and significantly reduces ambiguous (2+) read-outs.

    المؤلفون: Ciftlik, Ata Tuna, Lehr, Hans-Anton, Gijs, Martin A. M.

    المصدر: Proceedings of the National Academy of Sciences of the United States of America; 4/2/2013, Vol. 110 Issue 14, p5363-5368, 6p

    مصطلحات موضوعية: BIOMARKERS, BREAST cancer diagnosis, MICROFLUIDIC analytical techniques, IMMUNOHISTOCHEMISTRY, CANCER patients, HER2 protein, PROTEIN-tyrosine kinases, TRASTUZUMAB

    النص الكامل

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث